The Latest Cardiac and Vascular News
Eko honored for achievements in AI-powered solutions to improve cardiac care BERKELEY, Calif.–(BUSINESS WIRE)–Eko today announced that it has been named to CB Insights’ fourth annual AI 100 ranking, showcasing the 100 most promising private artificial intelligence companies in the world. “Eko has achieved numerous milestones over the past year, including partnerships with […]
Newcomers Deerfield, Qiming, Cormorant, and Invus join existing investors Third Rock and Google Ventures; Funding will enable Element Science to complete clinical studies, begin commercialization and develop a family of products SAN FRANCISCO–(BUSINESS WIRE)–Element Science, an innovative health technology company pioneering a next-generation digital wearable platform focused on high-risk cardiovascular […]
Former Amazon Director of Product Software and Services Brings Deep Expertise in Technology and Product Innovation MOUNTAIN VIEW, Calif., March 2, 2020 /PRNewswire/ — AliveCor, the leader in AI-based, personal ECG technology, and provider of enterprise cardiology solutions, today announced the appointment of Siva Somayajula, as its Chief Technology Officer. For more than […]
VANCOUVER, March 2, 2020 /PRNewswire/ – At the request of Investment Industry Regulatory Organization of Canada (“IIROC”), Correvio Pharma Corp. (NASDAQ: CORV) (TSX: CORV) (the “Company”) wishes to confirm that it is not aware of any material, undisclosed information related to the Company that would account for the recent increase in the market price and level […]
SAN FRANCISCO, Feb. 27, 2020 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today reported financial results for the three months and full year ended December 31, 2019. Fourth Quarter and Full Year 2019 Highlights — […]
LONDON–(BUSINESS WIRE)–Feb. 26, 2020– LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today reported results for the quarter and full-year ended December 31, 2019. For the fourth quarter of 2019, worldwide sales were $287.6 million, a decrease of 3.2 percent on a reported basis and a decrease of 2.2 percent on a […]
ENGLEWOOD, Colo., Feb. 27, 2020 /PRNewswire/ — 2019 Full Year Revenue increased 42% year over year to $45.5 million Net income $9.5 million; Diluted EPS $0.28 2019 Revenue, net income and Adjusted EBITDA are the highest in Company history Adjusted EBITDA increased 11% to $12.1M 2019 Fourth Quarter Revenue increased 52% year over year to $14.2 million […]
BRISBANE, Calif., Feb. 27, 2020 (GLOBE NEWSWIRE) — MyoKardia, Inc. (Nasdaq: MYOK), today reported financial results for the fourth quarter and full year ended December 31, 2019. “MyoKardia achieved significant progress in 2019, advancing our pipeline and regaining global rights to our entire portfolio. There were important data readouts across […]
– REBLOZYL® (luspatercept-aamt), a first-in-class erythroid maturation agent, was approved by the U.S. FDA for the treatment of anemia in adult patients with beta-thalassemia who require regular red blood cell transfusions; FDA review of the sBLA for the lower-risk myelodysplastic syndromes indication is ongoing – – Multiple clinical presentations reviewed at the […]
– Appoints Kevin R. Lind as President and Chief Executive Officer of Arena Neuroscience, Inc. – Appoints Laurie D. Stelzer as Executive Vice President and Chief Financial Officer of Arena – Expects to deliver up to eight major data readouts between 2020-21 and multiple INDs – Progressing first- or best-in-class […]
